Funding

California-Based SoundHealth Scores $12.25M in Series A Funding

Aug 1, 2026 | By Devin Jacobs

SUMMARY

SoundHealth has secured $12.25 million in Series A funding led by Shangbay Capital.
SoundHealth develops AI-powered, FDA-cleared, non-invasive medical devices that help improve breathing and sleep through personalized therapies.
The company will use the funding to expand its product portfolio and speed up the commercialization of its breathing and sleep wellness solutions.

SoundHealth, a San Francisco, CA-based provider of personalized, AI-enabled non-invasive medical and wellness devices for breathing and sleep disorders, has raised $12.25M in Series A funding round led by Shangbay Capital.

The fresh capital will help the company expand its portfolio of personalized, FDA-cleared therapeutics and accelerate the commercialization of its breathing and sleep wellness solutions.

Funding Snapshot

Metric	Details
Fundraise Amount	$12.25 Million
Funding Round	Series A
Lead Investor	Shangbay Capital
Company	SoundHealth
Sector	HealthTech, Medical Devices, AI
Headquarters	San Francisco, California, USA

RECOMMENDED FOR YOU

Startup News

David Readinger Promoted to Vice President at FirstService Residential

Devin Jacobs

Jul 2, 2026

Clasp Raises $20M Series B Funding

Devin Jacobs

Mar 28, 2026

Funding

Safire Group Raises $8 Million Pre-Series A Funding

Team SR

Sep 20, 2024

About SoundHealth

Founded by Paramesh Gopi, Bryant Lin, Peter Hwang, SoundHealth is a medical technology company focused on developing AI-powered, non-invasive, drug free devices that improve breathing and sleep health. Its technologies combine clinically validated science with proprietary artificial intelligence to deliver personalized treatments for millions of people affected by congestion, allergic rhinitis and sleep disorders.

The company's flagship product, Sonu, is an FDA-cleared acoustic resonance therapy device that has delivered more than 500,000 treatment sessions for users aged 12 and above. The company has also developed Spatial Sleep, a personalized sleep wellness device built using its proprietary craniofacial anatomical dataset, which has demonstrated the ability to help users fall asleep faster and sleep longer.

Recommended by more than 1,000 medical and dental professionals across the United States, SoundHealth is advancing non drug alternatives for respiratory, and sleep care.

Core offerings include:

AI-powered breathing therapy devices
FDA-cleared Sonu acoustic resonance therapy
Personalized sleep wellness solutions
Non-invasive treatments for congestion and sleep disorders

Core Technologies / Products / Services

Capability / Product	Application / Use Case
Sonu	FDA-cleared treatment for nasal congestion
Spatial Sleep	Personalized sleep wellness therapy
AI Personalization Platform	Customized breathing and sleep treatment
Craniofacial Anatomical Dataset	Precision therapy recommendations

Leadership Comments

“Shangbay's deep expertise in scaling medtech companies will benefit our growth trajectory. We are thrilled to have them as our Series A lead investor,” said Dr. Bryant Lin, Co-Founder of SoundHealth.

“We are excited to invest in SoundHealth's portfolio of non-invasive, FDA-cleared, AI-enabled therapeutics that address large, population-scale problems,” said William Dai, Founder of Shangbay Capital. “Their unparalleled dataset and proprietary algorithms have tremendous potential going forward.”